Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

Role of MR and PET in anti-voltage gated potassium channel (anti-VGKC-ab) antibody limbic encephalitis: A challenge ahead for simultaneous PET/MR

Athar Haroon, Rizwan Syed, Rizwan Basit, Simona Ben-Haim, Svetislav Gacinovic, Shelan Mahmood, Rayjanah Allie, Raymond Endozo, Jamshed Bomanji and Ashley Groves
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2005;
Athar Haroon
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rizwan Syed
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rizwan Basit
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simona Ben-Haim
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Svetislav Gacinovic
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelan Mahmood
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rayjanah Allie
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond Endozo
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamshed Bomanji
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Groves
1Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2005

Objectives Anti-VGKC-antibodies cause hyper-excitability of the peripheral and central nervous system. Clinical manifestations include episodic memory impairment, disorientation and agitation. It is auto-immune and potentially treatable. We aim to evaluate the role of combine MR and PET in this rare entity.

Methods We evaluated 6 cases of Anti-VGKC-ab referred for anatomical and metabolic imaging. MR of brain (T1, T2, FLAIR) and 18F FDG PET/CT scans of the whole body including brain were obtained. Patient’s demographics, VGKC levels, structural abnormalities on MRI and metabolic alterations were evaluated on 18F FDG PET/CT.

Results There were 5 male and 1 female patients (age range 55-76 years). The voltage gated potassium channel antibody levels were 298-5757 pM (normal range 0-100 pM). MRI showed following anatomical abnormalities: Increased signal on FLAIR in the hippocampi, punctiform whiter matter changes, cortical volume loss, increased T2 signal in the anterior temporal lobes, abnormal signal in the basal ganglia, hippocampal atrophy and increased T2 signal/FLAIR in the anterior limb of internal capsule. 18F FDG PET/CT showed following areas of altered cerebral metabolism Generalised hypometabolism in the temporal lobes, focal hypermetabolism in the medial temoral lobe and mild hypometabolism in the parietal lobes.

Conclusions Both MR and PET compliment the diagnostic yield in anti VGKC-antibody associated limbic encephalitis. Simultaneous PET/MR will facilitate early diagnosis and lesion characterization

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of MR and PET in anti-voltage gated potassium channel (anti-VGKC-ab) antibody limbic encephalitis: A challenge ahead for simultaneous PET/MR
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Role of MR and PET in anti-voltage gated potassium channel (anti-VGKC-ab) antibody limbic encephalitis: A challenge ahead for simultaneous PET/MR
Athar Haroon, Rizwan Syed, Rizwan Basit, Simona Ben-Haim, Svetislav Gacinovic, Shelan Mahmood, Rayjanah Allie, Raymond Endozo, Jamshed Bomanji, Ashley Groves
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2005;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of MR and PET in anti-voltage gated potassium channel (anti-VGKC-ab) antibody limbic encephalitis: A challenge ahead for simultaneous PET/MR
Athar Haroon, Rizwan Syed, Rizwan Basit, Simona Ben-Haim, Svetislav Gacinovic, Shelan Mahmood, Rayjanah Allie, Raymond Endozo, Jamshed Bomanji, Ashley Groves
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 2005;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET CT Quantification to direct Alzheimer’s patients to anti-amyloid therapy
  • Multicenter trial study for usefulness of physical parameters toward the standardization of brain SPECT image: relation to visual analysis
  • Assessment of Brain Perfusion 123I-IMP SPECT imaging Using Low Energy High Resolution Collimator image reconstructed by Flash 3D
Show more Neurosciences

MTA II: Neurology Posters

  • Correlation of metabolic and volumetric metrics of the structures of the temporal lobe on MRI and FDG-PET in patients with mesial temporal sclerosis
  • Evaluation of pre-operative invasive EEG and FDG PET in patients undergoing surgery for treatment of intractable temporal lobe epilepsy
  • Evaluation the cerebral blood perfusion in patients with severe carotid artery stenosis by 13N-ammonia PET/CT
Show more MTA II: Neurology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire